Assembled from the company's filings and exchange data as of today. Download PDF renders this page on the server; the narrative sections arrive with the Nexa composer.
Dossier · AMBANI ORGOCHEM LIMITED · 31 October 2026Page 1 of 3
Company Dossier
MarketPing Research · factual · no rating expressed
AMBANI ORGOCHEM LIMITED NSE: AMBANIORGO
AMBANI ORGOCHEM LIMITED
StateQ4 FY26 filed
Last close · 30 Oct 2026₹170.90
Market cap₹0.1k cr
TTM P/E · P/B · EV/EBITDA— · — · —
AMBANI ORGOCHEM LIMITED is a listed company listed on NSE. The annual-report business brief for this company has not been generated yet; the numbers below are as filed.
What a broker report prints here — the analyst's thesis. This dossier prints the filed record instead; the narrative read of the latest results, the guidance ledger and the earnings-call summary are the composer's sections (INSTITUTIONAL-PLAN.md M3) and are not yet produced.
Exhibit 1: Financial summary, FY25–FY26 (all audited; no estimate years)
₹ crore · consolidated
FY25
FY26
Revenue
193
241
EBITDA (ex other income)
9
10
margin %
4.9
4.0
Owners' profit
0
—
EPS, as reported (₹)
(2.11)
1.05
ROE % · ROCE %
(1.5) · 9.0
— · 13.6
Debt / equity (x)
0.95
—
Cash from operations
11
(0)
Capex
(20)
(9)
Source: SEBI results XBRL as filed with BSE/NSE; EBITDA excludes other income.
Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in
Dossier · AMBANI ORGOCHEM LIMITED · 31 October 2026Page 2 of 3
Exhibit 2: Quarterly performance, last 3 quarters
₹ crore
Q4 FY25
Q2 FY26
Q4 FY26
Revenue
111
109
132
Profit before tax
1
1
3
Net profit
1
—
—
EPS (₹)
0.42
0.24
0.80
Source: quarterly results as filed; the balance sheet is filed half-yearly and is not repeated here.
Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in
Dossier · AMBANI ORGOCHEM LIMITED · 31 October 2026Page 3 of 3
Exhibit 3: Filings of the last 90 days, with the measured price reaction
Date · filing
Category
Importance
Next day %
5-day %
29 Oct 2026 · Bhavin Patel resigns as non-executive non-independent director
management changes
medium
—
—
29 Oct 2026 · Bhavin Patel resigns as non-executive non-independent director
management changes
medium
—
—
28 Oct 2026 · Earnings call recording link submitted for half-year results
investor communications
low
—
—
27 Oct 2026 · Up to 43.92 lakh convertible warrants approved on preferential basis
fund raising
high
—
—
27 Oct 2026 · Shareholders approve convertible warrants and capital changes
corporate actions
medium
—
—
27 Oct 2026 · All four resolutions approved at first extraordinary general meeting
board shareholder meetings
low
—
—
26 Oct 2026 · H1 FY27 revenue up 55%, net profit jumps sharply; expansion roadmap outlined
investor communications
medium
—
—
26 Oct 2026 · EGM puts capital changes and preferential convertible warrants to vote
board shareholder meetings
low
—
—
21 Oct 2026 · Ambani Orgochem schedules H1 FY27 earnings call on Oct 27
board shareholder meetings
low
—
—
16 Oct 2026 · Corrigendum to EGM notice - convertible warrants issue size reduced
board shareholder meetings
low
—
—
Source: exchange announcements; each reaction is measured from the close before the filing. Next day = the close one session after the reaction day (the first session that could trade the filing).
How to read this document
Where a broker report shows
This document shows
Why
A rating (BUY / ADD / REDUCE / SELL)
A state: the latest filed quarter and the measured reactions
an event is a fact; a rating is an opinion that requires SEBI RA registration
A target price and upside
The current price and the multiples against the group
a target is a forecast; a multiple is a measurement
Estimate years marked E
More audited years; no estimates
MarketPing publishes no forecasts — your own model lives on the Models page
Sources, method and disclosures
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.
Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in
